Skip to main content
Arthritis Research & Therapy logoLink to Arthritis Research & Therapy
. 2016 Nov 4;18:257. doi: 10.1186/s13075-016-1164-1

Erratum to: Concentration of antibodies against Porphyromonas gingivalisis increased before the onset of symptoms of rheumatoid arthritis

Linda Johansson 1,#, Natalia Sherina 2,#, Nastya Kharlamova 2, Barbara Potempa 3, Barbro Larsson 2, Lena Israelsson 2, Jan Potempa 3,4, Solbritt Rantapää-Dahlqvist 1,✉,#, Karin Lundberg 2,#
PMCID: PMC5097366  PMID: 27814752

Erratum

Unfortunately, after publication of this article [1], it was noticed that the x-axis markers for Fig. 2a and b were incorrect. The corrected figure can be seen below.

Fig. 2.

Fig. 2

Antibody responses during the pre-dating time until the time point for onset of symptoms of RA, from pre-symptomatic individuals who donated multiple blood samples pre-dating the onset of symptoms of RA (n = 422) and from patients with RA (n = 192). Logarithmic mean concentrations during 2-year periods of anti-RgpB and anti-CPP3 antibodies in pre-symptomatic individuals, patients with RA and controls (n = 198) (a). Accumulated percentages of antibody positivity for anti-CPP3, anti-CCP2, anti-cfibrinogenβ36-52 (cFibβ36-52), anti-CEP-1 (α-enolase) and anti-cfilaggrin (cFilaggrin) antibodies in pre-symptomatic individuals and in patients with RA (b). 0 time point for onset of RA symptoms

Footnotes

The online version of the original article can be found under doi:10.1186/s13075-016-1100-4.

Reference

  • 1.Johansson L, Sherina N, Kharlamova N, Potempa B, Larsson B, Israelsson L, Potempa J, Rantapää-Dahlqvist S, Lundberg K. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res Ther. 2016;18:201. doi: 10.1186/s13075-016-1100-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Arthritis Research & Therapy are provided here courtesy of BMC

RESOURCES